Summus Company Overview
Summus is a leading virtual health company that offers employers, health plans, hospitals, health systems, and medical groups and networks a virtual care platform focused on specialty care, including peer-to-peer solutions that allow primary care and in-plan specialist providers access to a specialist network. Summus has been named to the New York Digital Health 100 for three consecutive years, a list that celebrates the most innovative and exciting healthcare organizations in New York. Summus has raised $70 million with investors that include the Glenstone Foundation and Mitchell Rales.
Summus Valuation History
Summus Stock Price
The stock price of Summus can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Summus has issued 250 million shares, at the estimated UpMarket valuation of $192.04 million, each share of Summus stock would be worth $0.77.
Buy Summus Stock
If you would like to buy shares in Summus, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Summus stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Summus as well.
Summus Management
Name | Position |
---|---|
Julian Flannery | CEO |